Table 1.
Baseline characteristics of 139 patients with isolated pelvic relapse.
| Variable | Value | Value |
|---|---|---|
| Age (mean/range) | 71.3 years | 43.9 to 88.8 years |
| Stage at initial diagnosis | n | % |
| IA | 71 | 51.08% |
| IB | 34 | 24.46% |
| II | 16 | 11.51% |
| III | 18 | 12.95% |
| Histology at primary diagnosis | ||
| Endometrioid adenocarcinoma | 111 | 79.86% |
| Serous/clear cell adenocarcinoma | 20 | 14.39% |
| Other * | 6 | 4.32% |
| Risk group at primary diagnosis for patients with stage I disease ** | ||
| Stage I low-risk | 49 | 36.30% |
| Stage I intermediate-risk | 36 | 26.67% |
| Stage I high-risk | 16 | 11.85% |
| Previous treatment | ||
| Hysterectomy/BSOE | 139 | 100% |
| Pelvic lymphadenectomy | 81 | 58.27% |
| Adjuvant chemotherapy | 28 | 20.14% |
* Carcinosarcoma (n = 3), adenosquamous (n = 2), unspecified (n = 1). ** Four patients with stage I disease could not be categorized due to missing information on grading.